Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Version 2 (2022-04-27) adds changes to Recruitment Status, Study Status, and Study Design in the record history. These updates reflect a shift in the trial's current enrollment and design information.
    Difference
    0.1%
    Check dated 2025-11-02T00:46:12.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Introducing a major status and governance notice plus a version upgrade to v3.2.0; old v3.1.0 tag removed. The core page now informs users about funding-related limitations and where to check operating status.
    Difference
    13%
    Check dated 2025-10-04T12:22:45.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical info.
    Difference
    0.3%
    Check dated 2025-09-27T07:58:19.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.0.2; removed Revision: v3.0.1 and Back to Top.
    Difference
    0.8%
    Check dated 2025-09-13T01:48:37.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.8%
    Check dated 2025-09-05T20:00:27.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    6%
    Check dated 2025-08-29T19:03:10.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.